Canakinumab-associated suppression of an mTOR-related serum proteomic signature after switching from tocilizumab in Still's disease
Kiyu Norimatsu, Tomohiro Koga, Shoichi Fukui, Kazusato Hara, Atsushi Kawakami; Canakinumab-associated suppression of an mTOR-related serum proteomic signat
Authors
- Shoichi Fukui (ORCID: https://orcid.org/0000-0001-5487-4692)
- 季遊 則松
- Atsushi Kawakami (ORCID: https://orcid.org/0000-0002-1512-8782)
- Kazusato Hara
- Tomohiro Koga (ORCID: https://orcid.org/0000-0003-2077-4428)
Institutions
- Nagasaki University (JP)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2026-09-29
- DOI
- https://doi.org/10.1093/rheumatology/keag526
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00